PKC412 是一種蛋白激酶C (PKC) 的抑制劑，同時可抑制 PKC 亞型 (α，β，γ)，PDFRβ，VEGFR2，Syk，PKCη，F(xiàn)lk-1，F(xiàn)lt3，Cdk1/B，PKA，c-Kit，c-Fgr，c-Src，VEGFR1 和 EGFR。
CNDAC產(chǎn)品描述：CNDAC is a major metabolite of oral drug sapacitabine, and a nucleoside analog. In Vitro: CNDAC-induced SSBs can be repaired by the transcription-coupled nucleotide excision repair pathway, wheras lethal DSBs are mainly repaired through homologous recombination. Deficiency in two Rad51 paralogs, Rad51D and XRCC3, greatly sensitize cells to CNDAC. The Rad51D-null cell line is approximately 50-fold more sensitive to CNDAC (IC50=0.006 μM) compared to 51D1.3, the Rad51D-repleted line (IC50=0.32 μM)[1]. CNDAC shows inhibitory activity against HL-60 and THP-1 cells with IC50s of 1.58 μM and 0.84 μM. CNDAC (10?μM) results in a significant dro in cell survival compared to the untreated on days 4, 7, and 14. CNDAC is more effective at reducing viability and inducing apoptosis than ara-C at equivalent concentrations in the THP-1 cell line, which is defined as displaying resistance to ara-C[2]. CNDAC induces DSBs, which are
公司介紹：MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫，總部位于美國新澤西，分別在瑞典和上海設(shè)有歐洲區(qū)子公司和亞洲區(qū)總代理，營銷網(wǎng)點遍及全球20多個國家地區(qū)。MCE經(jīng)過多年努力已成為全球生物活性小分子領(lǐng)域的一流供應(yīng)商， 產(chǎn)品涵蓋癌癥、神經(jīng)科學(xué)、抗感染、表觀遺傳學(xué)等20個熱門研究領(lǐng)域，PI3K、MAPK等近千個細分靶點，超過4000個活性小分子化合物現(xiàn)貨，以及GPCR、API、離子通道等超過20種不同類型的化合物庫，同時提供從毫克到千克的專業(yè)定制合成服務(wù)。
MCE 對每批產(chǎn)品都進行嚴格的LCMS和NMR檢驗，其產(chǎn)品已被全球近萬名客戶廣泛使用并發(fā)表大量文章、專利；
MCE 定期增加各領(lǐng)域熱門抑制劑、激動劑，不斷擴增已有化合物庫，以滿足最新的科研需求；
數(shù)千種產(chǎn)品在上海有充足備貨，24-48小時內(nèi)送達客戶；
大量產(chǎn)品提供免費試用裝； 已為全球多個知名企業(yè)、院校構(gòu)建各種定制型化合物庫。
產(chǎn)品鏈接：www.medchemexpress.cn/CNDAC.html
Purity:98%
MWt:570.6371
Formula:C35H30N4O4
SMILES:O=C(C1=CC=CC=C1)N(C)[C@H]2[C@@H](OC)[C@@]3(C)N(C4=C5C=CC=C4)C6=C5C7=C(C(NC7)=O)C8=C6N(C9=CC=CC=C98)[C@@](O3)([H])C2
Pathway:Epigenetics; TGF-beta/Smad;
Mechanisms:PKC;
Research Area:Cancer
電話： 021-58955995
網(wǎng)址： www.MedChemExpress.cn
地址： 上海市浦東新區(qū)蔡倫路720號2號樓3層
CNDAC產(chǎn)品描述：CNDAC is a major metabolite of oral drug sapacitabine, and a nucleoside analog. In Vitro: CNDAC-induced SSBs can be repaired by the transcription-coupled nucleotide excision repair pathway, wheras lethal DSBs are mainly repaired through homologous recombination. Deficiency in two Rad51 paralogs, Rad51D and XRCC3, greatly sensitize cells to CNDAC. The Rad51D-null cell line is approximately 50-fold more sensitive to CNDAC (IC50=0.006 μM) compared to 51D1.3, the Rad51D-repleted line (IC50=0.32 μM)[1]. CNDAC shows inhibitory activity against HL-60 and THP-1 cells with IC50s of 1.58 μM and 0.84 μM. CNDAC (10?μM) results in a significant dro in cell survival compared to the untreated on days 4, 7, and 14. CNDAC is more effective at reducing viability and inducing apoptosis than ara-C at equivalent concentrations in the THP-1 cell line, which is defined as displaying resistance to ara-C[2]. CNDAC induces DSBs, which are
公司介紹：MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫，總部位于美國新澤西，分別在瑞典和上海設(shè)有歐洲區(qū)子公司和亞洲區(qū)總代理，營銷網(wǎng)點遍及全球20多個國家地區(qū)。MCE經(jīng)過多年努力已成為全球生物活性小分子領(lǐng)域的一流供應(yīng)商， 產(chǎn)品涵蓋癌癥、神經(jīng)科學(xué)、抗感染、表觀遺傳學(xué)等20個熱門研究領(lǐng)域，PI3K、MAPK等近千個細分靶點，超過4000個活性小分子化合物現(xiàn)貨，以及GPCR、API、離子通道等超過20種不同類型的化合物庫，同時提供從毫克到千克的專業(yè)定制合成服務(wù)。
MCE 對每批產(chǎn)品都進行嚴格的LCMS和NMR檢驗，其產(chǎn)品已被全球近萬名客戶廣泛使用并發(fā)表大量文章、專利；
MCE 定期增加各領(lǐng)域熱門抑制劑、激動劑，不斷擴增已有化合物庫，以滿足最新的科研需求；
數(shù)千種產(chǎn)品在上海有充足備貨，24-48小時內(nèi)送達客戶；
大量產(chǎn)品提供免費試用裝； 已為全球多個知名企業(yè)、院校構(gòu)建各種定制型化合物庫。
產(chǎn)品鏈接：www.medchemexpress.cn/CNDAC.html
Purity:98%
MWt:570.6371
Formula:C35H30N4O4
SMILES:O=C(C1=CC=CC=C1)N(C)[C@H]2[C@@H](OC)[C@@]3(C)N(C4=C5C=CC=C4)C6=C5C7=C(C(NC7)=O)C8=C6N(C9=CC=CC=C98)[C@@](O3)([H])C2
Pathway:Epigenetics; TGF-beta/Smad;
Mechanisms:PKC;
Research Area:Cancer
電話： 021-58955995
網(wǎng)址： www.MedChemExpress.cn
地址： 上海市浦東新區(qū)蔡倫路720號2號樓3層
110102000668（1）號